Search Beyond News…

Sick leave duration capped at one month for first prescription

Executive summary: The French government published a decree limiting sick‑leave duration to one month for first prescriptions and two months for extensions, effective 1 September 2026. The policy seeks to reduce social‑security expenditures and balance employer cost pressures while potentially affecting employee leave rights.

Who is involved: French Ministry of Health, Social Security administration, employer federations, labour unions.

Likely next: Implementation will be monitored, with possible legal challenges and adjustments before the September start date.

The French government published a decree limiting sick‑leave duration to one month for a first prescription and two months for extensions, effective 1 September 2026. The measure is part of the 2026 Social Security financing law and aims to curb rising benefit costs while addressing employer concerns. Reactions range from employer support for cost control to union concerns about employee rights.

What's next — scenarios

Fiscal Stabilization (Base Case) (50%)

Reduced absenteeism costs for corporations without significant erosion of labor peace.

Labor Unrest & Litigation (Downside) (30%)

Increased operational disruption due to strikes and rising legal compliance costs for HR departments.

Systemic Under-reporting (Upside for State/Downside for Quality) (20%)

Improvement in social security solvency at the expense of long-term workforce health and productivity.

What to watch

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Historical parallels

Sources

Related cases

Browse the full archive →